Peter Lang
University Childrens Hospital Tübingen · University Children's Hospital Tuebingen · University Hospital Tuebingen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Lang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:13 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05366218 · Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage LeukemiaUniversity Hospital Tuebingen · recruiting · ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory · principal investigator
- Ph1/Ph2NCT03559413 · Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALLUniversity Children's Hospital Tuebingen · completed · Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults · principal investigator
- Ph2NCT02258815 · CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed NeuroblastomaUniversity Children's Hospital Tuebingen · completed · Neuroblastoma Recurrent · principal investigator
- Ph1/Ph2NCT01919866 · Safety Study of CD3/CD19 Depleted Haploidentical Stem CellsUniversity Children's Hospital Tuebingen · unknown · Acute Leukemias, Aplastic Anemia, Childhood Solid Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 15 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:13 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- 171 citationsRCR 5.7
- 106 citationsRCR 3.3
- Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.Br J Haematol · 201476 citationsRCR 2.5
- Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial.Br J Haematol · 201860 citationsRCR 2.1
- 29 citationsRCR 1.3
- Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.Bone Marrow Transplant · 201919 citationsRCR 0.8
- Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia.Pathol Biol (Paris) · 200513 citationsRCR 0.4
- 8 citationsRCR 0.4
- Therapy response correlates with ALDH activity in ALDH low-positive childhood acute lymphoblastic leukemias.Pediatr Hematol Oncol · 20142 citationsRCR 0.1